APA

Ryall R. L., Grover P. K., Stapleton A. M., Barrell D. K., Tang Y., Moritz R. L. & Simpson R. J. (19960216). The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted human urine in vitro. : Clinical science (London, England : 1979).

Chicago

Ryall R L, Grover P K, Stapleton A M, Barrell D K, Tang Y, Moritz R L and Simpson R J. 19960216. The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted human urine in vitro. : Clinical science (London, England : 1979).

Harvard

Ryall R. L., Grover P. K., Stapleton A. M., Barrell D. K., Tang Y., Moritz R. L. and Simpson R. J. (19960216). The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted human urine in vitro. : Clinical science (London, England : 1979).

MLA

Ryall R L, Grover P K, Stapleton A M, Barrell D K, Tang Y, Moritz R L and Simpson R J. The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted human urine in vitro. : Clinical science (London, England : 1979). 19960216.